These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Sollinger HW. Transplantation; 1995 Aug 15; 60(3):225-32. PubMed ID: 7645033 [Abstract] [Full Text] [Related]
4. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group. Transplantation; 1998 Jan 27; 65(2):235-41. PubMed ID: 9458021 [Abstract] [Full Text] [Related]
6. Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation. Merion RM, Henry ML, Melzer JS, Sollinger HW, Sutherland DE, Taylor RJ. Transplantation; 2000 Jul 15; 70(1):105-11. PubMed ID: 10919583 [Abstract] [Full Text] [Related]
7. Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group. Transplantation; 1999 Aug 15; 68(3):391-6. PubMed ID: 10459543 [Abstract] [Full Text] [Related]
8. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group. Transplantation; 1996 Mar 15; 61(5):722-9. PubMed ID: 8607174 [Abstract] [Full Text] [Related]
12. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups. Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C. Transplantation; 1997 Jan 15; 63(1):39-47. PubMed ID: 9000658 [Abstract] [Full Text] [Related]